XiraHist Side Effects
Generic name: carbinoxamine / phenylephrine
Note: This document provides detailed information about XiraHist.
Applies to carbinoxamine/phenylephrine: oral drops, oral liquid, oral tablet extended release Side Effects associated with carbinoxamine / phenylephrine. Some dosage forms listed on this page may not apply specifically to the brand name XiraHist.
Applies to carbinoxamine/phenylephrine: oral drops, oral liquid, oral tablet extended release.
General adverse events
General side effects have included weakness and pallor.[Ref]
Nervous system
Nervous system side effects have included central nervous system stimulation, tremors, convulsions, nervousness, insomnia, headache, sedation, and dizziness.[Ref]
Gastrointestinal
Gastrointestinal side effects have included dry mouth, nausea, anorexia, heartburn, and diarrhea.[Ref]
Genitourinary
Genitourinary side effects have included dysuria and polyuria.[Ref]
Hematologic
Hematologic side effects have included unusual bleeding or bruising, anemia and blood dyscrasias.[Ref]
Psychiatric
Psychiatric side effects have included mood or mental changes, hallucinations, and psychotic episodes.[Ref]
Hypersensitivity
Hypersensitivity side effects have included allergic reactions and tightness in the chest.[Ref]
Respiratory
Respiratory side effects have included respiratory difficulty.[Ref]
Cardiovascular
Cardiovascular side effects have included arrhythmias, increased heart rate, and increased blood pressure.[Ref]
References
1. (2005) "Product Information. Norel LA (carbinoxamine-phenylephrine)." U.S. Pharmaceutical Corporation
More about XiraHist (carbinoxamine / phenylephrine)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Further information
XiraHist side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.